Verano Holdings (VRNO) Accounts Payables (2021 - 2026)

Verano Holdings' (VRNO) quarterly Accounts Payables came in at $29.0 million in Q1 2026, down 36.21% year-on-year from $45.4 million in Q1 2025, and down 25.24% on a QoQ basis from $38.7 million in Q4 2025.

Verano Holdings (VRNO) Accounts Payables (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Accounts Payables data on file, last reported at $29.0 million in Q1 2026.

  • On a quarterly basis, Accounts Payables fell 36.21% year-over-year to $29.0 million in Q1 2026; TTM through Mar 2026 was $29.0 million, a 36.21% decrease from a year earlier, with the FY2025 full-year figure at $38.7 million, down 2.98% from the prior year.
  • Accounts Payables for Q1 2026 stood at $29.0 million, down from $38.7 million in the prior quarter.
  • Over the last five years, Accounts Payables for VRNO reached as high as $60.8 million in Q2 2022 and fell as low as $25.2 million in Q2 2024.
  • Historically, Accounts Payables has averaged $38.3 million across 5 years, with a median of $39.2 million in 2025.
  • Across the five-year window, Accounts Payables sank 42.91% in 2023 and jumped 60.37% in 2025, its largest moves.
  • Year by year, Accounts Payables stood at $40.5 million in 2022, then retreated by 22.76% to $31.3 million in 2023, then rose by 27.64% to $39.9 million in 2024, then dropped by 2.98% to $38.7 million in 2025, then slipped by 25.24% to $29.0 million in 2026.
  • Per Business Quant data, the three most recent Accounts Payables figures were $29.0 million in Q1 2026, $38.7 million in Q4 2025, and $42.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 4.96 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 2.60 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 507.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.13 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 498.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 1.67 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.75 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 773.00 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 372.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn 28.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.96 Mn
Dec 31, 2025 38.74 Mn
Sep 30, 2025 42.32 Mn
Jun 30, 2025 39.67 Mn
Mar 31, 2025 45.40 Mn
Dec 31, 2024 39.93 Mn
Sep 30, 2024 42.49 Mn
Jun 30, 2024 25.20 Mn
Mar 31, 2024 28.31 Mn
Dec 31, 2023 31.28 Mn
Sep 30, 2023 31.02 Mn
Jun 30, 2023 34.73 Mn
Mar 31, 2023 30.52 Mn
Dec 31, 2022 40.50 Mn
Sep 30, 2022 52.21 Mn
Jun 30, 2022 60.83 Mn
Dec 31, 2021 45.17 Mn